Dr. Chamberlain testified that he confirmed the structure of
each compound by biological tests, including NMR analysis,
elemental analysis, and mass spectroscopy (Exh. 2019 at ¶¶5-
15, Exh. 2022, and Exh. 2023). Below is a list of the
compounds said to be within the scope of the count and said to
have been synthesized by Chamberlain in February and March of
1994 along with the SC identification of each (Paper 46 at 7-
12):
(1) 4-[3-(4-fluorophenyl)-benzofuran-2-yl]
benzenesulfonamide
(SC-60246)
(2) 3-(3-chloro-4-methoxyphenyl)-2-
[4-(methylsulfonyl)phenyl]benzofuran
(SC-60247)
(3) 3-(3-fluoro-4-methoxyphenyl)-2-
[4-(methylsulfonyl)phenyl]benzofuran
(SC-60248)
(4) 4-[3-(3-fluoro-4-methoxy phenyl)-
benzofuran-2-yl]benzenesulfonamide
(SC-60667)
(5) 4-[3-(3-chloro-4-methoxyphenyl)-
benzofuran-2-yl]benzenesulfonamide
(SC-60668)
Dr. Chamberlain testified that the syntheses were
recorded in his notebook (Exh. 2015).
The Koboldt testing
42. Koboldt testified that, on 16 September 1993,
she received material identified as SC-58394 from Dr. Henry
16
Page: Previous 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 Next
Last modified: November 3, 2007